OQROStart free trial
Politician trade (Senate)

Johnson & Johnson (JNJ): Sen. Jerry Moran disclosed a sale $1K–$15K

Sen. Jerry Moran disclosed a sale of Johnson & Johnson in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
34 days
Disclosure lag
Traded
Dec 14, 2023
Disclosed
Jan 17, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 21, 2023CongressDisclosed sale of JNJ — reported range $100,001 - $250,000
  2. Sep 26, 2023CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  3. Oct 16, 2023CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  4. Oct 24, 2023CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  5. Dec 5, 2023Congress · 2 peopleMembers of Congress: 2 purchases
  6. Dec 14, 2023 · this disclosureCongressDisclosed sale of JNJ — reported range $1,001 - $15,000

What came next

  1. Dec 14, 2023CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  2. Jan 19, 2024Congress · 1 personMembers of Congress: 2 sales
  3. Jan 23, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  4. Feb 20, 2024FDAFDA drug approval: Tecvayli
  5. Feb 26, 2024FDAFDA device clearance: FMS VUE™ Fluid Management and Tissue Debridement System
  6. Mar 1, 2024FDAFDA drug approval: Rybrevant
  7. Mar 5, 2024Congress · 2 peopleMembers of Congress: 2 purchases
  8. Mar 8, 2024FDARecall: STRATAFIX Spiral MONOCRYL Plus Bidirectional Knotless Tissue Control Device: STRATAFIX SPIRAL MONOCRYL PLUS BI UD 12+12IN(30+30CM) USP3-0(M2) D/A PS PRM- Indic…
  9. Mar 12, 2024FDARecall: ATTUNE AFFIXIUM Cementless Fixed Bearing Knee with 3DP Technology, Size 6. Component of the ATTUNE Total Knee Replacement System.
  10. Mar 14, 2024FDARecall: Johnson & Johnson VISION Reusable LAMINAR High Flow Irrigation Sleeve and Test Chamber 21 Gauge REF OPOHF21L The irrigation sleeve is a device intended to dire…
  11. Mar 15, 2024FDAFDA drug approval: Edurant
  12. Mar 15, 2024FDAFDA drug approval: Edurant
  13. Mar 15, 2024FDAFDA drug approval: Edurant Ped
  14. Mar 15, 2024FDAFDA device clearance: MILAGRO Interference Screw; MILAGRO ADVANCE Interference Screw
  15. Mar 21, 2024FDAFDA device clearance: DePuy Synthes VOLT Mini Fragment Plating System, DePuy Synthes VOLT Small Fragment Plating System
  16. Mar 21, 2024FDAFDA device clearance: ATTUNE Total Knee System, ATTUNE Cementless Knee System, LPS Limb Preservation System, Sigma High Performance (HP) Partial Knee System
  17. Mar 22, 2024FDAFDA drug approval: Opsynvi
  18. Mar 22, 2024FDAFDA device clearance: Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave E8 Peripheral IVL Catheter
  19. Apr 4, 2024FDAFDA device clearance: PINNACLETM Constrained Acetabular Liners
View the official recordSenate eFD periodic transaction report

How to read Senate eFD periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Johnson & Johnson

For Johnson & Johnson, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports, 119 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.

Other recent filings by Sen. Jerry Moran

The full history of Sen. Jerry Moran is on the profile page.

How this filing works

Explore the data

Other disclosures at Johnson & Johnson

Everything OQRO holds on this company is on its JNJ page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Start free trialAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data